Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Results from CheckMate-227 : Immune combination reaches PFS endpoint

Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA

Results from CheckMate-227 : Immune combination reaches PFS endpoint ( Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA )

Editor's Choice for February 2018

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for February 2018 ( Prof Gordon McVie - Founding Editor, ecancer )

6-factor prognostic model for patients with advanced urothelial carcinoma

Dr Gregory Pond - McMaster University, Hamilton, Ontario

6-factor prognostic model for patients with advanced urothelial carcinoma ( Dr Gregory Pond - McMaster University, Hamilton, Ontario )

Comment: Urothelial cancer research from ASCO GU 2018

Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA

Comment: Urothelial cancer research from ASCO GU 2018 ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )

VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and...

Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK

VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis ( Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK )

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or...

Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification ( Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium )

Updates on non-metastatic castration-resistant prostate cancer

Prof Kurt Miller, Prof Silke Gillessen, Prof Heather Payne and Dr Eric Small

Updates on non-metastatic castration-resistant prostate cancer ( Prof Kurt Miller, Prof Silke Gillessen, Prof Heather Payne and Dr Eric Small )

Updates in metastatic prostate cancer

Prof Heather Payne, Dr Neal Shore, Dr Eleni Efstathiou, Prof Nicolas Mottet

Updates in metastatic prostate cancer ( Prof Heather Payne, Dr Neal Shore, Dr Eleni Efstathiou, Prof Nicolas Mottet )

Neoadjuvant and adjuvant therapy in triple negative breast cancer

Prof Banu Arun - MD Anderson Center, Houston, USA

Neoadjuvant and adjuvant therapy in triple negative breast cancer ( Prof Banu Arun - MD Anderson Center, Houston, USA )

The DESKTOPIII trial in platinum-sensitive ovarian cancer

Prof Sean Kehoe - University of Birmingham, Birmingham, UK

The DESKTOPIII trial in platinum-sensitive ovarian cancer ( Prof Sean Kehoe - University of Birmingham, Birmingham, UK )

Developing drugs for personalised medicine

Prof Simon Hollingsworth - AstraZeneca, Cambridge, UK

Developing drugs for personalised medicine ( Prof Simon Hollingsworth - AstraZeneca, Cambridge, UK )

Advancements in the treatment and management of patients with castration...

Prof Kurt Miller and Prof David Dearnaley

Advancements in the treatment and management of patients with castration resistant prostate cancer ( Prof Kurt Miller and Prof David Dearnaley )

More from ecancer